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Abstract
Objectives: The purpose is to evaluate in vivo at rest and under stress conditions hemodynamic performance of the small size St. Jude 
Medical Regent (SJMR) prosthetic valve in patients with a body surface area (BSA) of 1.8±0.11 m2 and to define the role of valve prosthesis- 
patient mismatch on left ventricular mass regression following aortic valve replacement. Methods: We evaluated 25 cases (12 males and 
13 females, mean age 65.2±8 years) of aortic valve replacement (17 mm SJMR in three cases and 19 mm SJMR in 22 cases). All the patients 
underwent at rest Doppler echocardiography before and after surgery and both basal and dobutamine stress echocardiography (DSE) at 
follow-up. The mean duration of follow-up was 41.3±24 months. Results: A significant reduction in mean and peak transaortic gradients and 
peak transaortic velocity over time following valve replacement has been identified. After surgery, there was a significant increase of ejec-
tion fraction. DSE significantly increased heart rate, ejection fraction, peak transaortic gradient and peak transaortic velocity. All patients 
passed DSE without complication. Even if a significant mismatch was present in 76% of cases, the left ventricular mass decreased significantly 
from preoperative value of 278.7±51.1 g to 181.5±52.73 g, respectively. Conclusion: Aortic valve replacement with 17 mm SJMR or 19 mm 
SJMR prostheses appear to provide satisfactory clinical and hemodynamic results at rest and under DSE, even in those patients with BSA of 
1.8±0.11 m2 where it was not possible to enlarge the aortic annulus. Prosthesis-patient mismatch is not associated with lesser regression of 
left ventricular mass. Dobutamine stress echocardiography should be a useful and effective means for evaluating prosthesis hemodynamic 
aspects.
 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Aortic valve replacement (AVR) is the standard therapy 
for patients with severe aortic stenosis; there has been 
persistent improvement in hemodynamic status results. 
With the aging population, greater numbers of patients 
are exhibiting aortic stenosis; thus, the number of patients 
undergoing AVR is increasing. However, AVR in small aortic 
root patients is still a challenge for the cardiac surgeon 
with regard to operative technique and prosthesis selec-
tion. Since the introduction of the concept of prosthesis-
patient mismatch (PPM) by Rahimtoola [1], implantation of 
a small prosthesis in the aortic position has been blamed 
for residual gradients, that are responsible for poor left 
ventricular mass regression, increased long-term mortal-
ity and more valve-related complications [2, 3]. Various 
strategies to increase the effective orifice area (EOA) of 
the implanted valve have been described, such as the aor-
tic enlargement or replacement with a larger prosthesis, 
like a stentless bioprosthesis or a new generation supraan-
nular mechanical prosthesis. Some of those techniques are 
more difficult, for instance they require longer cross-clamp 
times, and they are associated with higher hospital mortal-
ity rates than isolated AVR, with no increase in long-term 
survival [4, 5].
The St. Jude Medical Regent (St. Paul, MN, USA) is a new 
bileaflet aortic valve that represents a design evolution of 
SJM Hemodynamic Plus Series (HP) valve [6, 7]. Its modified 
outer profile, along with a larger inside lumen area of the 
prosthesis, should improve hemodynamic by increasing the 
EOA of the valve.
The purpose is the evaluation in vivo at rest and in a 
stress condition, by performing dobutamine stress echo-
cardiography (DSE) [8], hemodynamic performance of this 
prosthetic valve in patients with body surface area (BSA) 
of 1.8±0.11 m2 but with a small annulus. Besides, we want 
to define the role of valve prosthesis-patient mismatch 
on left ventricular mass regression following aortic valve 
replacement.
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2. Materials and methods
2.1. Patient population
The study population consisted of 25 patients with a 
mean age of 65.2±8 years (12 males and 13 females); it 
was 41.3±24 months before they had received a 17 mm 
SJMR in three cases and in 22 cases a 19 mm SJMR aortic 
valve, after sizing the aortic annulus. All patients pre-
sented important annulus and aortic root calcification at 
the time of operation. In none of the cases has it been 
possible to attempt the enlargement of the aortic annu-
lus. All demographic and clinical data are summarized in 
Table 1.
2.2. Operative technique
Aortic valve surgery was performed through a standard 
median sternotomy. Cardiopulmonary bypass was initi-
ated after cannulation of the ascending aorta, superior 
and inferior vena cava. A left ventricular vent was inserted 
by means of the right upper pulmonary vein. Anterograde 
crystalloide cardioplegia (St. Thomas II) was administered 
to maintain cardiac arrest. Moderate hypothermia was 
applied. After complete excision of the diseased aortic 
valve, the diameter of the aortic annulus was measured 
with sizers (St. Jude Medical, St. Paul, Minnesota, USA) 
for selection of the appropriate prosthesis size. Prostheses 
were implanted supraannularly with interrupted sutures 
reinforced by Gore-Tex pledget in all patients. Warfarin 
sodium was started on the day of surgery and continued 
thereafter so that the international normalized ratio of 
prothrombin time was maintained between 2.0 and 2.5.
2.3. Protocol study
All patients underwent basal echocardiography before 
cardiac surgery and one month after surgery. Preoperative 
and perioperative data were obtained by retrospective 
review of clinical and surgical records. At mean distance 
of 41.3±24 months after surgery patients were enrolled in 
the study and underwent rest echocardiography and DSE. 
β-Blockers were discontinued in all patients 24 h before the 
test, whilst patients on ace-inhibitors and calcium antago-
nists continued their medication. Informed written consent 
was obtained from all patients. Dobutamine was infused 
intravenously starting at 5 μg/kg/min and increased by 
5 μg/kg/min at five minute intervals up to 25 μg/kg/min. 
During the study, patients underwent continuous electrocar-
diographic monitoring, and blood pressure was recorded at 
five minute intervals with an automated cuff. Criteria for 
stopping the dobutamine infusion included: (1) hypotension 
(systolic blood pressure <100 mmHg); (2) dyspnea; (3) signif-
icant ventricular and supraventricular arrhythmias. Repeat 
(stress) Doppler measurements were obtained before each 
incremental increase in the infusion rate. Following the 
completion of the final assessment at a dose of 25 μg/kg/
min (maximum stress), dobutamine infusion was discon-
tinued, and the patient was monitored for a minimum of 
20 min, or until heart rate (HR) had returned to pre-stress 
values.
2.4. Echocardiographic measurements and calculations
Examinations included M-mode, two-dimensional (2D), 
continuous wave and pulsed Doppler, and color Doppler 
analysis. Left parasternal, apical and periapical, subcostal, 
and suprasternal standard views were employed.
Standard M-mode dimensions were obtained according 
to the American Society of Echocardiography criteria. The 
mean of three measures of two different cardiac cycles was 
taken. The following variables were obtained: end-diastolic 
septal thickness, left ventricular end-diastolic diameter 
and left ventricular end-systolic diameter. All Doppler mea-
surements were averaged from more than three cycles in 
sinus rhythm patients and more than five cycles in the atrial 
fibrillation ones. The peak and the mean transprosthetic 
gradients were calculated using the modified Bernoulli 
equation. Left ventricular mass was calculated according to 
the Devereux formula [9]. The in vivo EOA was calculated 
using continuity equation method [10]: EAO=(LV outflow 
cross-section area)×(subvalvular flow/supravalvular flow). 
The EOA index (EAOi) was calculated by dividing EOA by 
BSA. The criteria are an EOAi of <0.85 cm2/m2 for moderate 
PPM and <0.65 cm2/m2 for severe PPM [11]. Left ventricular 
ejection fraction (EF) was calculated using the apical four-
chamber view and the application of the modified Simpson 
rule method [12].
2.5. Statistical methods
Value is expressed as the mean±standard deviation 
(S.D.). Simple comparison was performed using a standard 
χ2-test or non-paired t-test. A P<0.05 value was considered 
significant.
Table 1. Demographic and clinical patient characteristics
Clinical variable Median Mean S.D.
Follow-up (months) 40 41.3 24
Age 68 65.2 8
Body surface area (BSA) (m2) 1.8 1.8 0.11
Body mass index (BMI) 28 28.7 3.93
Size LVOT (cm) 1.9 1.92 0.17
Preoperative ejection fraction (EF) (%) 59 56.7 6.72
Number of patients %
Male 12 48
Female 13 52
Aortic valve stenosis 24 96
Aortic valve incontinence 5 20
Ischemic heart disease 6 24
Diabetes 6 24
Broncopneumapatia 2 8




 grade I 0 0
 grade II 2 8
 grade III 20 80
 grade IV 3 12
Aortic valve replacement
 St. Jude 17 (mm) 3 12
 St. Jude 19 (mm) 22 88
 Aortocoronary bypass 6 24
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of lifespan. Authors proposed a three-step algorithm for 
its prevention, as follows: (1) calculate the patient's BSA; 
(2) determine the minimal valve EOA required to ensure an 
EOAi >0.85 cm2/m2, given the patient's BSA as calculated in 
step 1; and (3) select the type and size of prosthesis that has 
reference values for EOA≥the minimal EOA value obtained 
in step 2. Nevertheless, in those patients with a large BSA 
and relatively small aortic annulus requiring AVR, the native 
annulus may not fit the size of the prosthesis required and 
so the surgeon faces the problem of whether to perform an 
annular enlargement procedure or to possibly compromise 
the surgical result by accepting PPM. Sometimes, this pro-
cedure is technically difficult and it requires an increase in 
cross-clamp time. This variable has been suggested to be 
associated with increased mortality following AVR. The use 
of a small size St. Jude Medical Regent mechanical valve 
[13, 14] has been proposed in patients with small annulus 
when aortic enlargement is not attempted. Its modified 
outer profile, along with a larger inside lumen area of the 
prosthesis, should improve hemodynamic by increasing the 
EOA of the valve. To confirm this speculation, we study, in 
vivo at rest and in a stress condition (DSE), the hemody-
namic performance of 17 mm and 19 mm SJM Regent (SJMR) 
mechanical valve implanted in a study population of 25 
patients with mean BSA was 1.8±0.11 m2 and a small aortic 
annulus. In none of the cases has the enlargement of the 
aortic annulus has been possible because it appeared tech-
nically difficult. We analyzed several anatomical, hemody-
namic and clinical parameters, such as left ventricular mass, 
resting and stressed heart rate, ejection fraction, transval-
vular gradient and velocity, as well as clinical well-being. 
3. Results
Preoperative and postoperative echocardiographic data 
are reported in Table 2. A significant increasing of ejec-
tion fraction was observed after surgery (56.72±6.72% vs. 
62.6±5.2%, P<0.00001). The basal transaortic maximal 
flow velocity passed from 4.89±0.59 m/s to 2.7±0.5 m/s 
(P<0.00001), as a result mean and peak transprosthetic gra-
dient decreased, respectively, from 57.56±17.75 mmHg to 
17.12±5.98 mmHg (P<0.00001) and from 91.12±21.52 mmHg 
to 32.12±11.35 mmHg (P<0.00001). We observed a signifi-
cant decreasing of left ventricular dimensions and of the 
interventriculae septum thickness. Left ventricular mass 
decreased from preoperative values of 278.7±51.1 g to 
181.5±52.73 g (P<0.00001).
After surgery EOAi was 0.78±0.3 cm2/m2. According to 
Pibarot definitions, 76% of patients had significant PPM 
(Fig. 1).
All patients completed DSE without complications. Three 
patients had occasional premature atrial and/or ventricu-
lar beats, which did not preclude them from completing 
the test. Echocardiographic data at rest and under DSE at 
follow-up are reported in Table 3.
With dobutamine heart rate increased from baseline of 
76±13 beats/min to 118±11 beats/min (P<0.00001); ejec-
tion fraction increased from baseline of 62.6±5.2% to 
67.92±4.8% (P<0.00001). Basal systolic and diastolic blood 
pressure did not change significantly during the test. At 
peak dobutamine, the maximal transprosthetic flow veloc-
ity increased from baseline to 2.7±0.5 m/s to 4.3±0.93 m/s 
(P<0.00001); the mean and the peak transprosthetic gra-
dients increased significantly from baseline, by achieving, 
respectively, 42.76±18.23 mmHg and 71.36±30.54 mmHg 
(P<0.00001 and P<0.00001). EAO and EAOi changed during 
the test but there was an insignificant increase. The mean 
NYHA class did not change significantly during or after the 
test.
4. Discussion
Pibarot and colleagues [11] defined PPM as being present 
if the EOAi was <0.85 cm2/m2. Furthermore, PPM was con-
sidered as moderate if the EOAi was between 0.65 cm2/m2 
and 0.85 cm2/m2 and severe if it was <0.65 cm2/m2. PPM 
can result in persistent left ventricular outflow obstruc-
tion, which increases left ventricular work and reduces left 




Fig. 1. Percentage of patients that presented prosthesis-patient mismatch 
according Pibarot definition. Pibarot and colleagues defined PPM as being 
present if the effective orifice area index was <0.85 cm2/m2. Furthermore, 
PPM was considered as moderate if the EOAi was between 0.65 cm2/m2 and 
0.85 cm2/m2 and severe if it was <0.65 cm2/m2. EOAi, effective orifice area 
index; PPM, prosthesis-patient mismatch.
Table 2. Preoperative and postoperative echocardiographic data
Variable Preoperative mean value S.D. Postoperative mean value S.D. P-value
Ejection fraction (%)  56.72  6.72  62.6  5.2 <0.00001
Peak transaortic velocity (m/s)  4.89  0.59  2.7  0.5 <0.00001
Mean gradient (mmHg)  57.56 17.75  17.12  5.98 <0.00001
Peak gradient (mmHg)  91.12 21.52  32.12 11.35 <0.00001
End-systolic diameter (cm)  35.42  6.38  31.16  5.41 <0.00001
End-diastolic diameter (cm)  48.36  5.44  42.36  5.2 <0.00001
Interventriculae septum (cm)  12.96  1.45  11.04  1.69 <0.00001
End-systolic volume (ml)  42.4 15.56  29.48  8.76 <0.00001
End-diastolic volume (ml)  97.12 25.75  78.84 18.97 <0.00001
Left ventricular mass (g) 278.7 51.1 181.5 52.73 <0.00001
S.D., standard deviation.
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6. Conclusions
Aortic valve replacement with 17 mm SJMR or 19 mm 
SJMR prostheses appears to provide satisfactory clinical 
and hemodynamic results at rest and under DSE, even in 
patients with BSA of 1.8±0.11 m2 and a small aortic annu-
lus. The appreciable increase of the gradient and the strain 
associated with undersized valves under stressed conditions 
is evidently necessary for the heart to provide (otherwise) 
normal hemodynamics.
Prosthesis-patient mismatch is not associated with lesser 
regression of left ventricular mass.
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Pisano et al. [1] describe a difficult group of patients requiring a mechani-
cal valve, but having a small calcified aortic root, making a root enlarg-
ing procedure potentially hazardous. Their methods and conclusions raise a 
number of issues.
The effective orifice area (EOA) was calculated using the continuity 
equation method [2]: EOA = (LV outflow cross-section area)×(subvalvular 
flow/supravalvular flow). This means that the cardiac output is an impor-
tant factor. With no documentation of cardiac output assessment pre- 
and post-dobutamine stress testing, interpretation of the EOA is difficult. 
The use of heart rate, although useful, does not directly correlate with 
increased cardiac output due to the shortening of diastole, and the dia-
stolic dysfunction that is virtually universal in patients with aortic valve 
disease.
Doppler is notoriously inaccurate in patients with atrial fibrillation. The 
number of patients that had this pre- and postoperatively at the time of 
investigation was unspecified in the manuscript. Atrial fibrillation is asso-
ciated with left ventricular hypertrophy, making it a potentially important 
confounding factor [3], as the effects on regression are unknown.
Left ventricular mass regression is not just dependent on aortic steno-
sis, but also the presence of systemic hypertension, and the stage of valve 
disease that is being operated on. As half the patients were hypertensive, 
were these the ones that had LV regression due to their hypertension being 
adequately managed postoperatively?
Even in the presence of patient-prosthesis mismatch, patients with normal 
left ventricular function will have left ventricular mass regression as the 
ventricle is being off-loaded, even if not adequately.
Patient-prosthesis mismatch in the small annulus is potentially critical in 
patients with poor ventricular function, and suggesting such extrapolation of 
data from patients with good ventricular function may be premature.
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